Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy.

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™.

The Tiny, Portable, and Economical Mini 16™ Ultra-Fast Portable qPCR Machine is designed for Point-of-Care Testing, Research, and Veterinary Applications

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.

Primerdesign Ltd is excited to announce the release of the World's Most Affordable DNA Testing System. The genesig q16 accompanies a catalogue of over 400 easy to use DNA testing kits which encompass a range of practical applications.

AnaSpec is pleased to annuounce new series of FAST MasterMixes for SYBR® and Probe Assays from Eurogentec.